Chemoinformaics analysis of 1,3,6-Heptatriene, 2,5,6-trimethyl-
| Molecular Weight | 136.238 | nRot | 3 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 3 |
| Exact Molecular Weight | 136.125 | nRing | 0 |
| Solubility: LogS | -3.688 | nHRing | 0 |
| Solubility: LogP | 3.365 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.3687 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.412 |
| Synth | 4.091 |
| Natural Product Likeliness | 2.492 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.294 |
| MDCK | 0.0000202 |
| BBB | 0.969 |
| PPB | 0.663948 |
| VDSS | 1.939 |
| FU | 0.321726 |
| CYP1A2-inh | 0.573 |
| CYP1A2-sub | 0.835 |
| CYP2c19-inh | 0.111 |
| CYP2c19-sub | 0.89 |
| CYP2c9-inh | 0.048 |
| CYP2c9-sub | 0.791 |
| CYP2d6-inh | 0.273 |
| CYP2d6-sub | 0.847 |
| CYP3a4-inh | 0.139 |
| CYP3a4-sub | 0.331 |
| CL | 8.284 |
| T12 | 0.563 |
| hERG | 0.011 |
| Ames | 0.029 |
| ROA | 0.026 |
| SkinSen | 0.142 |
| Carcinogencity | 0.61 |
| EI | 0.992 |
| Respiratory | 0.411 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.944956 |